ConcertAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, ConcertAI announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology treatments.